Background: Supraventricular tachycardias (SVTs), despite having various anatomical substrates and pathophysiological mechanisms, frequently show similar electrocardiographic presentations.
Objectives: To locate and characterize atrial deflections (ADs) on 12-lead electrocardiograms in dogs with sustained rapid SVT and assess the utility of different electrocardiographic variables in differentiating types of tachycardia.
Animals: Ninety-two dogs with orthodromic atrioventricular reciprocating tachycardia, 17 with atrial flutter, 33 with focal atrial tachycardia recorded and confirmed by electrophysiological study, and 40 dogs with sinus tachycardia.
Methods: Atrial deflection position on the 12-lead surface electrocardiogram was assessed according to the sequence of intracardiac activation. Its features were evaluated together with the relationship between AD and QRS complex interval (AD-R) and QRS complex and AD interval (R-AD).
Results: Orthodromic atrioventricular reciprocating tachycardia was characterized by an AD-AD interval of 213 ± 30 ms, mean electrical axis (MEA) of AD of -90 (-90/-78)°, R-AD interval of 75 (65-80) ms, and R-AD/AD-R of 0.54 (0.45-0.64). Atrial flutter was characterized by an AD-AD interval of 199 ± 57 ms, MEA of 76° (72/81), R-AD of 120 (72-144) ms, and R-AD/AD-R of 0.81 (0.63-1.13). Focal atrial tachycardia was characterized by an AD-AD interval of 270 ± 38 ms, MEA of 49 (-72/76)°, R-AD of 160 (120-200) ms, and R-AD/AD-R of 1.45 (0.92-1.67). Sinus tachycardia was characterized by an AD-AD interval of 292 ± 31 ms, MEA of 66° (52/73), R-AD of 215 (192-222) ms, and R-AD/AD-R of 2.68 (2.25-3.08).
Conclusions And Clinical Importance: Analyzing AD on 12-lead electrocardiogram is helpful in differentiating the most common SVTs in dogs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658594 | PMC |
| http://dx.doi.org/10.1111/jvim.16845 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Atherogenic Dyslipidemia Is Critically Related to Aortic Complicated Lesions in Cryptogenic Stroke.
J Atheroscler Thromb
December 2024
Department of Neurology, Juntendo University Urayasu Hospital.
Aims: Atherogenic dyslipidemia (AD) is regarded as a residual risk of cardiovascular diseases characterized by low high-density lipoprotein cholesterol (HDL-C) and high triglyceride (TG) levels and related to the intracranial stenosis of atheromatous thrombotic brain infarction (ATBI). Further, atherosclerosis is possibly related to another stroke subtype, including cryptogenic stroke (CS). In particular, an aortic complicated lesion (ACL) is a notable embolic source of CS, since recurrence of aortogenic brain embolism is not rare.
View Article and Find Full Text PDFIdentification of isoAsp7-Aβ as a major Aβ variant in Alzheimer's disease, dementia with Lewy bodies and vascular dementia.
Acta Neuropathol
December 2024
Paul Flechsig Institute - Centre of Neuropathology and Brain Research, University of Leipzig, Liebigstraße 19, 04103, Leipzig, Germany.
Article Synopsis
- - The study investigated the role of various post-translational modifications of amyloid-β (Aβ) in different types of dementia, highlighting how specific Aβ variants could characterize distinct dementia forms, including Alzheimer's disease (AD) and other dementias like Lewy body dementia and vascular dementia.
- - Researchers analyzed post-mortem brain tissues using immunohistochemical techniques and machine learning to quantify various Aβ modifications, finding that AD tissues had the highest levels of Aβ variants compared to other conditions.
- - Notably, the isoAsp7-Aβ variant was found abundantly across all dementia types, while other modifications displayed varying distributions in plaque types and cerebral blood vessels, with some variants detected intraneuronally rather
The Alzheimer's Disease Neuroimaging Initiative Neuropathology Core: An update.
Alzheimers Dement
November 2024
Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Introduction: Biomarkers for Alzheimer's disease neuropathologic change (ADNC) have been instrumental in developing effective disease-modifying therapeutics. However, to prevent/treat dementia effectively, we require biomarkers for non-AD neuropathologies; for this, neuropathologic examinations and annotated tissue samples are essential.
Methods: We conducted clinicopathologic correlation for the first 100 Alzheimer's Disease Neuroimaging Initiative (ADNI) Neuropathology Core (NPC) cases.
Cord Blood Serum Levels of IL-31 and CCL17, Cutaneous Markers, and Development of Atopic Dermatitis.
JAMA Dermatol
October 2024
Unit of Dermatology, Department of Medical and Oncology Area, University of Pisa, Pisa, Italy.
Article Synopsis
- - Atopic dermatitis (AD) is a common chronic skin condition, but there is currently no effective way to predict which newborns are at risk for developing it.
- - A study evaluated specific serological biomarkers in 40 newborns to see if they could predict the development of AD, using measurements from cord blood and skin assessments at various ages.
- - Findings indicated that infants who developed AD showed significantly higher levels of certain biomarkers at birth, suggesting potential predictive indicators for the condition.
In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives.
Alzheimers Dement
August 2024
Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Introduction: The recent introduction of seed amplification assays (SAAs) detecting misfolded α-synuclein, a pathology-specific marker for Lewy body disease (LBD), has allowed the in vivo identification and phenotypic characterization of patients with co-occurring Alzheimer's disease (AD) and LBD since the early clinical or even preclinical stage.
Methods: We reviewed studies with an in vivo biomarker-based diagnosis of AD-LBD copathology.
Results: Studies in large cohorts of cognitively impaired individuals have shown that cerebrospinal fluid (CSF) biomarkers detect the coexistence of AD and LB pathology in approximately 20%-25% of them, independently of the primary clinical diagnosis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!